{"entity":{"id":"idea-reg-confirmatory-trial-escrow","kind":"idea","name":"Sponsors deposit the confirmatory trial budget in escrow at accelerated approval","aka":[],"tldr":"To get an early approval, a company would set aside the money for the follow-up trial up front, so the trial cannot be quietly abandoned.","summary":"Confirmatory trials for accelerated approvals are often delayed or redesigned in ways that reduce their chance of a clear answer. The proposal is a financial escrow: at approval the sponsor deposits the estimated cost of the pre-agreed confirmatory trial with an independent trustee. The funds are released against enrolment and reporting milestones; if the sponsor defaults, the trustee funds an academic cooperative group to complete the trial. This complements, rather than replaces, an automatic sunset.","asOf":"2026-09-08","links":[{"label":"Bottleneck evidence (Regulatory divergence between regions): FDA Oncology Center of Excellence, Project Orbis","url":"https://www.fda.gov/about-fda/oncology-center-excellence/project-orbis"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["accelerated-approval"],"trials":[],"people":[],"bottlenecks":["b-regulatory-fragmentation","b-incentive-misalignment"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hypothesis":"Escrow-backed confirmatory trials reach their primary readout a median of 18 months sooner than historical confirmatory trials, and the proportion never reported falls to near zero.","rationale":"Escrow converts a soft regulatory commitment into a hard financial one and creates a funded route for independent completion when commercial interest wanes (for example after a competing product launches). Environmental remediation bonds work on the same logic.","test":"Legislative pilot in one region for new accelerated oncology approvals; compare time to confirmatory readout with concurrent non-escrow approvals elsewhere.","maturity":"speculative","actor":"policy","cost":"small","horizonYears":6},"route":"/ideas/idea-reg-confirmatory-trial-escrow/","neighbours":{"term":[{"id":"accelerated-approval","kind":"term","name":"Accelerated approval","route":"/terms/accelerated-approval/"}],"bottleneck":[{"id":"b-incentive-misalignment","kind":"bottleneck","name":"Incentives reward me-too drugs and marginal gains","route":"/bottlenecks/b-incentive-misalignment/"},{"id":"b-regulatory-fragmentation","kind":"bottleneck","name":"Regulatory divergence between regions","route":"/bottlenecks/b-regulatory-fragmentation/"}],"roadmap":[{"id":"trial-modernisation-roadmap","kind":"roadmap","name":"Trial modernisation roadmap: the randomised trial → platforms and adaptive designs → decentralised, pragmatic and always-on","route":"/roadmaps/trial-modernisation-roadmap/"}]}}